SAN DIEGO, May 8, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ImmunityBio, Inc. (NASDAQ: IBRX) publicly traded securities between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"), have until...
Hence then, the article about investor deadline immunitybio inc ibrx investors with substantial losses have opportunity to lead securities class action lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit )
Also on site :
- Trump claims doubled gas prices are ‘way down’ as his transport chief tells Americans to take road trips
- Sewage treatment and desalination: Saudi Arabia’s core infrastructure opportunity – World Construction Network
- Robert Irwin Reveals Prince George, Princess Charlotte and Prince Louis Named the Newest Addition at Australia Zoo